Renaissance Technologies - EIGER BIOPHARMACEUTICALS INC ownership

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of EIGER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$50
-88.1%
71,700
-84.7%
0.00%
-100.0%
Q1 2023$419
+15.4%
467,682
+52.2%
0.00%
Q4 2022$363
-100.0%
307,300
+131.3%
0.00%
-100.0%
Q3 2021$888,000
+210.5%
132,884
+295.2%
0.00%
Q2 2021$286,000
-69.8%
33,625
-68.5%
0.00%
-100.0%
Q1 2021$946,000
-48.7%
106,884
-60.6%
0.00%
-50.0%
Q1 2020$1,844,000
-13.5%
271,184
+89.5%
0.00%0.0%
Q4 2019$2,133,000
+3.3%
143,129
-28.9%
0.00%0.0%
Q3 2019$2,064,000
-34.8%
201,329
-32.6%
0.00%
-33.3%
Q2 2019$3,165,000
-18.8%
298,613
+7.1%
0.00%
-25.0%
Q1 2019$3,899,000
+51.6%
278,929
+10.2%
0.00%
+33.3%
Q4 2018$2,572,000
-23.1%
253,129
-9.2%
0.00%0.0%
Q3 2018$3,346,000
-24.4%
278,813
-29.3%
0.00%
+50.0%
Q2 2018$4,425,000
+173.8%
394,258
+140.4%
0.00%0.0%
Q1 2018$1,616,000
+19.4%
164,029
+69.1%
0.00%
+100.0%
Q4 2017$1,353,000
+55.7%
97,013
+22.8%
0.00%0.0%
Q3 2017$869,000
+369.7%
79,013
+237.3%
0.00%
Q2 2017$185,00023,4250.00%
Other shareholders
EIGER BIOPHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 135,848$2,024,0006.74%
INTERWEST VENTURE MANAGEMENT CO 764,918$11,397,0004.91%
Knoll Capital Management, LLC 350,238$5,219,0003.85%
683 Capital Management, LLC 1,850,000$27,565,0003.15%
Soleus Capital Management, L.P. 205,407$3,060,0002.95%
Broadfin Capital, LLC 1,236,368$18,422,0002.47%
P.A.W. CAPITAL CORP 144,000$2,146,0002.29%
MANGROVE PARTNERS IM, LLC 847,284$12,625,0001.85%
Corriente Advisors, LLC 203,898$3,038,0001.63%
Trellus Management Company, LLC 63,850$951,0001.59%
View complete list of EIGER BIOPHARMACEUTICALS INC shareholders